Brief: Epigenomics: voluntary public takeover offer by Summit Hero Holding not successful
12/07/2017 12:30
July 12 (Reuters) - EPIGENOMICS AG ECXn.DE :
* EPIGENOMICS AG: VOLUNTARY PUBLIC TAKEOVER OFFER BY SUMMIT
HERO HOLDING NOT SUCCESSFUL
* SAYS MINIMUM ACCEPTANCE THRESHOLD OF 75.0 PERCENT HAS NOT
BEEN REACHED
* SAYS WE NOW WILL CAREFULLY EXPLORE ALTERNATIVE FINANCING
OPTIONS
Source text for Eikon: ID:nEQ2V0tFba
Further company coverage: ECXn.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns